TY - JOUR JO - EuroIntervention TI - Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial AB - <p class="text-1er-paragraph"><span class="abstracts-titres">Aims:</span> The study sought to investigate clinical and multimodality imaging assessment of a bioresorbable sirolimus-eluting scaffold (NeoVas, Lepu Medical, Beijing, China) for patients with AU - Zhang Yao-Jun AU - Wang Xiao-Zeng AU - Fu Guo-Sheng AU - Jing Quanmin AU - Wang Geng AU - Jin Chong-Ying AU - Xie Lihua AU - Cai Jin-Zan AU - Xu Bo AU - Han Ya-ling VL - 12 IS - 10 Y1 - 20/11/2016 Y1 - 2016 DOI - 10.4244/EIJV12I10A209 SP - 1279 EP - 1287 KW - bioresorbable scaffold KW - first-in-man KW - intravascular ultrasound KW - neovas KW - optical coherence tomography KW - sirolimus PB - Europa Digital & Publishing SE - CORONARY INTERVENTIONS UR - https://eurointervention.pcronline.com/article/clinical-and-multimodality-imaging-results-at-6-months-of-a-bioresorbable-sirolimus-eluting-scaffold-for-patients-with-single-de-novo-coronary-artery-lesions-the-neovas-first-in-man-trial SN - 1774-024X ER -